分享好友 环球市场首页 环球市场分类 切换频道

Asia Pacific Medical Foods Market (2025 - 2030)

2024-10-1100

Asia Pacific Medical Foods Market Trends

The Asia Pacific medical foods market size was estimated at USD 6.90 billion in 2024 and is projected to grow at a CAGR of 6.27% from 2025 to 2030. The region has a large patient pool and geriatric population, and lifestyle changes are leading to an increase in the prevalence of various diseases, such as cancer, diabetes, gastrointestinal disorders, & autoimmune diseases. For instance, according to data published by WHO in 2023, Thailand has one of the world’s most rapidly aging populations, with 12 million of 67 million residents classified as elderly. In 2021, the estimated percentage of the population older than 65 years was 13.2%, an increase from 12.6% estimated in 2020. Hence, the demand for medical foods for the dietary management of chronic diseases is expected to increase.

Moreover, Japan and China have a large elderly population, which is at a high risk of chronic conditions. Nutritional deficiencies are more common in the geriatric population, which is expected to boost the demand for medical foods in the region. A UN Agencies report stated that the number of undernourished people in Asia increased from 361.3 million to 418.0 million between 2019 and 2020, raising the rate of undernourishment from 7.9% to 9.0%.

The increase in preterm births is expected to boost the adoption of medical foods in the region during the forecast period. For instance, according to an article published by WHO, in 2020, India reported the highest number of estimated 3.02 million preterm births, which accounted for around 23% of all preterm births across the globe.

Medical foods are essential for preterm infants, addressing their unique nutritional needs due to underdeveloped organs and low birth weight. These formulas provide vital nutrients like proteins, fats, vitamins, and minerals in easily digestible forms to support growth, organ development, and immune function. By promoting healthy weight gain and neurological development, medical foods help reduce complications and improve long-term health outcomes. They play a critical role in the care of preterm infants and ultimately contribute to the market's growth.

Furthermore, various government initiatives undertaken to expand the market are anticipated to impel the market growth. For instance, on May 19, 2023, Japan's Consumer Affairs Agency revised the labeling guidelines for Food for Special Dietary Uses (FOSDU), allowing companies to apply for FOSDU certification for Oral Rehydration Solution (ORS) products. The amendment created a new category for companies that develop and market ORS products as medical foods. This initiative is expected to likely increase the variety of ORS products tailored for specific medical conditions, such as dehydration due to illness or during post-surgery recovery.

The Chinese government has progressively strengthened the regulatory framework for Foods for Special Medical Purposes (FSMPs), with growing advocacy for future reimbursement coverage. The regulatory oversight for FSMPs is managed by the National Medical Products Administration (NMPA), formerly the China Food and Drug Administration (CFDA), which facilitates product approvals and supports market growth. As of September 2024, China had 206 registered FSMPs, with key examples in the table below.

Asia Pacific Medical Foods Market

举报
收藏 0
评论 0